Please watch my new YouTube video: Quick Pick Merck

Please watch my new YouTube video: Quick Pick Merck

Today’s stock pick of the week is Merck, (MRK). Merck’s “problem” is that one of its biggest revenue streams comes from Keytruda, an oncology drug that will be going off-patent in 2028. In 2023, Merck projected new oncology drugs would bring in an additional $10 billion to replace Keytruda’s revenue. At this year’s JPMorgan healthcare conference, the company’s projection was even higher at $20 billion by the 2030s.

Moderna shares jump today on positive results in skin cancer vaccine trials

Moderna shares jump today on positive results in skin cancer vaccine trials

Shares of Moderna (MRNA) closed up 925% today, December 14. A personalized vaccine developed by Merck and Moderna helped prevent the recurrence of severe skin cancer for three years, according to new results released today. Patients with severe melanomas who got the vaccine and Merck’s cancer drug Keytruda were 49% less likely to die or have their cancer return than those who got Keytruda alone. The news is especially important for Moderna.

Bonus Special Report: Where to Park Your Cash

Bonus Special Report: Where to Park Your Cash

The advice is sound, very sound. Move part (at least of your portfolio to cash and sit out the worst of this bear market on the sidelines. And since you have that cash in hand, you’ll be ready to snap up bargains when the market has put in a bottom (or near the bottom, or on the way up from the bottom…or something.) But right now that’s easier said than done.

The big uncertainties in Merck’s covid pill

The big uncertainties in Merck’s covid pill

Stocks zoomed on Friday on news that Merck (MRK) had developed and successfully trialed a pill that ... To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing...

A summary of the changes to my Dividend Portfolio in my Special Report 3 Ways to Higher Income in a Low Yield Desert

Just to put all the changes in my Dividend Portfolio in one list after my Special Report 3 Ways to Higher Income in a Low Yield Desert Here are the sells: Bank of America (BAC) as of November 1 ING Group (ING) as of November 1 Tapestry (TPR) as of November 1 Westpac...